RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Dr. Reddy's Laboratories 2021-02-25 Health serious CPSC
Health · CPSC · Recall #CPSC-21089

Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg Recall

Issued February 25, 2021 · Dr. Reddy's Laboratories · 21,400 units affected

In February 2021, Dr. Reddy's Laboratories recalled the Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg, a serious health recall reported by the CPSC.

Compiled by Maya Ellison, RecallCheckr

What this means for you

The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

What you should do

  1. 1 Stop using Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Dr. Reddy's Laboratories to arrange your refund. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Refund): Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

Recall details

Brand
Dr. Reddy's Laboratories
Category
Health
Recall date
February 25, 2021
Units affected
21,400
Sold at
Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
Recall number
CPSC-21089
Made in
India
Issuing agency
CPSC

In context

  • Dr. Reddy's Laboratories has 1 recall in our database.
  • We're tracking 3,576 Health recalls in our database.
  • 21,400 units is enough to reach roughly 1 in every 6,121 US households.
  • This is the 7th Health recall we've logged in 2021.
Read the official CPSC notice

Related recalls